FinanceCity
HealthcareNSE · BSE

Poly Medicure Ltd

POLYMED · ISIN INE205C01021

Share price

₹1,510 -0.07%

Market capitalisation

₹15321 CrClosed

Live from Yahoo Finance. Pulse animates during NSE market hours (9:15–15:30 IST, weekdays).

01 · Key metrics

Market cap

₹15321 Cr

Current price

₹1,510

-0.07% today

52W high

₹2,317

52W low

₹1,182

Stock P/E

47.6

P/B ratio

4.93

02 · Per share & returns

EPS (TTM)

₹31.72

Book value

₹306

ROE

10.85%

ROA

5.75%

Dividend yield

0.23%

Beta

0.06

03 · Financials (TTM)

By the numbers

Revenue

₹1875 Cr

+21.30% YoY

EBITDA

₹442 Cr

Net profit

₹322 Cr

-26.80% YoY

Profit margin

17.18%

Operating margin

13.50%

Total debt

₹354 Cr

Total cash

₹827 Cr

Debt / equity

0.11x

Current ratio

3.37x

Payout ratio

11.02%

04 · Analyst view

Target price

₹1,579

Upside

+4.57%

Consensus

NONE

Analysts

6

05 · Shareholding pattern

Who owns POLYMED?

  • Promoters

    62.42%

    Founders & promoter group

  • Institutions

    21.77%

    FII + DII

  • Public

    15.81%

    Retail & non-institutional

As of 31 Mar 2026 · Source: NSE corporate filings

06 · Registration & listing

On the record

Symbol
POLYMED
Exchange
NSE · BSE
CIN
ISIN
INE205C01021
BSE code
531768
Sector
Healthcare
Industry
Healthcare
Face value
₹5
Listing date
06 Dec 2011
Employees
Headquarters
New Delhi, India

07 · About

What is Poly Medicure Ltd?

Poly Medicure Limited engages in the manufacture and sale of medical devices in India and internationally. The company offers infusion therapy products, such as I.V Infusion set, extension lines, needle free connector, I.V flow regulator extension set, burette set, three way stop cock, vial access spike, transfer spike, orburator, polyflush, maifolds, polyswab, and arterial blood collection; critical care products, including vial access spikes, arterial cannula, mini mid lines over the wire, extension line, enteral connector, central venous catheters, and huber needle; dialysis and renal care products, comprising peritoneal dialysis set, haemocent, standard and safety fistula needle, dialyzer, bloodlines and dialysis system. It also provides cardiology products PTFE wire, inflation device, Y-connector, manifold, introducer, IV Cannula, hydrophilic wire, guiding catheter, drug eluting stent, PTCA dilation catheter, diagnostic catheter, and electrocardiograph electrodes; vaccular access products; oncology products; diagnostics products, such as blood collection tubes, safety blood collection set, blood collection needles, and standard needle holder. In addition, the company offers transfusion system products, including blood bags, blood administration set, and others; anesthesia and respiratory care products, comprising variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, aerosol therapy masks, ventilator circuits, suction catheters, spinal needle, polyciser, oxygen catheter, nebulizer compressor system, twin bore nasal oxygen cannula mucus extractor, HME filter, oro-pharyngeal airways, endotracheal tubes, catheter mount, and brain circuit; urology products, including urine collection bags, leg bag set, irrigation sets, foley balloon and urine drainage catheters, and urine collection bags with measured volume meters; wound drainage; and gastroenterology products. The company was incorporated in 1995 and is based in New Delhi, India.

08 · Common questions

Frequently asked

What is the CIN of Poly Medicure Limited?+

The Corporate Identity Number for Poly Medicure Limited is published in the MCA21 corporate master. FinanceCity backfills CIN values during weekly refreshes.

Who are the promoters of Poly Medicure Limited?+

Promoter holding in POLYMED is approximately 62.42%, as disclosed in the latest published shareholding pattern.

What is the market capitalisation of Poly Medicure Limited?+

Poly Medicure Limited (POLYMED) has a market capitalisation of approximately ₹15321 Cr, reflecting the most recent weekly refresh from the BSE scrip master.

09 · Adjacent

Other healthcare listings

Full sector →